Only first 10,000 results will be saved in the file.
No item is selected. Use checkboxes to select search results.
Displaying 801-825 of 1083 results.
{{ selectedCountPage }} items selected on this page,{{ selectedCountPage }} item selected on this page,{{ selectedCountTotal }} item in total{{ selectedCountTotal }} items in total
Study aim:
Determining the effect of Mentha longifolia spray on clinical and paraclinical status of patients with COVID-19
Design:
This study is a phase 1 and 2 clinical trial, randomized, and also has a control group which has been done on 60 patients. Study is not blind. The random allocation process will
Study aim:
The study of the effect of herbal drug phyllanthus Emblica, Rosa Damascene, Althaea Officinalis and Honey in patient with covid19 referring to Ahvaz Jundishapur University of Medical Science (...) ) test confirmed infection with COVID19. 3. Lung involvement in imaging 4. Hospitalized 5. Less than 8
Study aim:
Comparative assessment of the efficacy and safety of addon treatment with “Sofosbuvir-Daclatasvir”, “Lithium”, and “Trifluoprazine” to “standard of care in three groups of patients with COVID-19(...) with COVID-19 admitted to Golestan hospital of Kermanshah. 80 eligible patients will be selected
Study aim:
Evaluating the therapeutic effect of a mixed herbal drink of marshmallow and licorice on covid19 patients, a double blind clinical trial
Design:
Randomize double blind clinical trial (...) ≥18 years
2. Polymerase chain reaction (PCR) test confirmed infection with COVID19.
3. Lung
Study aim:
The evaluation of safety and efficacy of Pembrolizumab (CinnaGen Co, Iran) in patients with COVID-19
Design:
This is a phase II, open-label, and single-arm study with the sample size of 62 (...) will be conducted in patients with COVID-19 with a follow-up duration of at least 7 days. Pembrolizumab
Study aim:
Determining and comparing the effect of pomegranate tea with placebo in relief patients' symptoms and reducing the duration of disease in patients with COVID-19
Design:
66 patients with COVID-19 will be randomly assigned to two groups of placebo and intervention by a pharmacognosy specialist based
Study aim:
Evaluation effects of multimodal rehabilitation on recovery of ICU Acquired Weakness following COVID-19 infection
Design:
Quasi-experimental clinical trial, without control group, without (...) groups:
Patients with COVID-19 with a history of ICU admission, with Or without Mechanical ventilation
Study aim:
Improving general health in patients infected with Covid-19, by using virtual education (...) ) being diagnosed with COVID through PCR test or typical pattern through X-ray or CT Scan 2) a mild form (...) infected and hospitalized due to COVID 5) having background lower and upper motor neuron diseases 6) lack
Study aim:
Evaluation of the immunologic effects of COVID-19
vaccination following autologous stem (...) (anti-S1) titer at four weeks post second COVID-19 vaccine than pre vaccination titer in autologous HSCT (...) old who underwent autologous SCT and agree to receive post-transplant COVID-۱۹ vaccines, provided they
Study aim:
Comparison of training with different intensities with consumption in obese people in order to prevent Covid19
Design:
A randomized, double-blind, randomized controlled clinical trial on 60 healthy obese individuals. Excel software rand function was used for randomization.
Settings and
care on reducing anxiety in patients with Covid19
Design:
This study is a clinical trial that has a (...) simple that the target population is patients hospitalized with Covid19 in Imam Reza (AS) Hospital in (...) its target population is patients with Covid19 in Imam Reza (AS) Hospital in Mashhad. In the present
criteria:
COVID-19 patients that have positive PCR test
COVID-19 patients that have positive by CT Scan for COVID-19.
Exclusion criteria: Pregnant or breast feeding women, Patients under 18 years of age (...) and conduct:
investigation of clinical symptoms and laboratory findings due to use of Grapex on covid
comparison with standard treatment in improving the symptoms of high-risk COVID19 patients.
Design:
A (...) on 60 patients.
Settings and conduct:
This study was performed on patients with COVID-19 hypoxia (...)COVID-19 have high-risk conditions
positive laboratory sample
Exclusion criteria:
Pregnancy
History of
, cognitive function and balance of older adults who recovers from COVID19
Design:
A semi-experimental (...) a distance of 10 meters without aids. The severity of COVID19 in these people is at level 1 whose (...) falling; Reducing the side effect of Covid19.
quality of work lifeof nurses working on the front lines of the fight against Covid-19
Design:
A phase (...) on the Covid-19 frontline. A table of random numbers will be used.
Settings and conduct:
This (...) against Covid-19 who will participate in a stress-based mindfulness training program for 8 sessions
Study aim:
To investigate the effectiveness of telephone‐delivered treatment for psychological disorders of COVID-19 survivors in Tehran, the capital of Iran.
Design:
Non-randomized- non blinded (...) .
Participants/Inclusion and exclusion criteria:
Screening part: COVID-19 survivors who will refer to a Imam
Study aim:
The Effect of Inspiratory muscle training in quality of life, aerobic capacity and pulmonary functional index in patients with COVID-19 in Masih-Daneshvari hospital
Design:
control group,parallel, randomized groups, Simple randomization method
Settings and conduct:
All patients who meet the
Study aim:
Dose finding, safety and immunogenicity of Covid19 FAKHRAVAC (MIVAC) inactivated (...) laboratory findings; No current or previous infection with COVID-19; Use of safe methods of contraception (...) medical or surgical attention; High-risk occupations exposed with Covid-19; serving in obligatory military
Study aim:
Determining the effect of Using of Pulmonary Rehabilitation at Home on Pulmonary Function, anxiety and depression in Patients with Covid19 In Afzalipoor Hospital
Design:
A clinical trial with 70 patients with Covid will be performed by simple random allocation using sealed and numbered
-intensity pneumonia caused by covid19.
Participants/Inclusion and exclusion criteria:
Inclusion criteria
18- to 75-year-olds with moderate-intensity pneumonia caused by Covid19 whose disease has been (...) tablets for 5 consecutive days. In the control group, placebo is added to the usual treatment for covid19
patients with Covid-19
Design:
This study was designed as a double-blind randomized controlled clinical (...) /Inclusion and exclusion criteria:
Inclusion criteria :Includes people with laboratory confirmation of Covid virus 19
Age over 15 years
Exclusion criteria
Patient request to leave the study for any reason
Request
Study aim:
Study on the effect of educational intervention based on precede model on the quality of life in pregnant women referring to health centers in Arak duration of pandemic COVID-19
Design (...)COVID and do not have mental and physical diseases affecting the quality of life, who have access to the